6/06/22

Research

Charcot Marie Tooth

PXT3003 Update

New Data from the Open-Label PLEO-CMT-FU Trial Shows SustainedBenefit with PXT3003 in Patients with Charcot-Marie-Tooth Disease Type1A After 5 Years […]

Continue Reading

Connect with us

Last Updated: Tuesday 7th March, 2023